Related Experiment Video
Updated: May 5, 2026
10:38
Isolation of Early Hematopoietic Stem Cells from Murine Yolk Sac and AGM
Published on: June 27, 2008
14.7K
[Cell salvage in obstetrics-Background and practical implementation]
Mischa J Kotlyar1, Vanessa Neef2, Florian Rumpf3
1Klinik und Poliklinik für Anästhesiologie, Intensivmedizin, Notfallmedizin und Schmerztherapie, Universitätsklinikum Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland. kotlyar_m@ukw.de.
Die Anaesthesiologie
|November 14, 2024
Summary
Postpartum hemorrhage (PPH) management needs improvement due to rising transfusion rates. Cell salvage (CS) can reduce red blood cell (RBC) transfusions, but its use in obstetrics is low despite evidence of safety and efficacy.
Area of Science:
- Obstetrics and Gynecology
- Anesthesiology
- Transfusion Medicine
Context:
- Postpartum hemorrhage (PPH) is a major cause of maternal mortality globally, with increasing incidence and associated allogeneic red blood cell (RBC) transfusions in Western countries.
- The risks and scarcity of allogeneic RBC transfusions necessitate optimized blood management strategies in obstetrics.
- Patient blood management (PBM) techniques, including cell salvage (CS), are increasingly adopted, showing improved patient outcomes.
Purpose:
- To review the current evidence on the utilization and safety of cell salvage (CS) in obstetric patients.
- To address the low adoption rate of CS in German hospitals for peripartum hemorrhage, despite its benefits.
- To provide practical guidance and organizational recommendations for implementing CS in obstetric care, particularly during cesarean sections.
Summary:
- Cell salvage (CS) is a patient blood management (PBM) technique that reinfuses a patient's own blood during major bleeding, potentially reducing the need for allogeneic red blood cell (RBC) transfusions.
- Despite evidence supporting CS's efficacy in reducing RBC transfusions and improving outcomes, its use in German obstetrics is minimal (0.07% of births with peripartum hemorrhage).
- Concerns regarding patient safety (e.g., amniotic fluid embolism, alloimmunization) and unfamiliarity with the technique contribute to the low utilization of CS in obstetric settings.
Impact:
- Increased understanding and potential adoption of cell salvage (CS) in obstetric care can lead to reduced reliance on allogeneic red blood cell (RBC) transfusions.
- Improved patient blood management (PBM) strategies, including CS, can mitigate risks associated with transfusions and enhance maternal outcomes.
- Implementation of CS may help address the rising incidence of PPH and associated transfusion needs, particularly in high-risk procedures like cesarean sections.
